New devices in glaucoma surgery

Expert Review of Ophthalmology

Volumn 4, Issue 5, 2009, Pages 491-504

  Rao, Kavita ^a   Ahmed, Ike ^b   Blake, Diane A ^c   Ayyala, Ramesh S ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative glaucoma device; Aqueous humor drainage; Glaucoma surgery; Reactive fibrosis; Traditional glaucoma drainage device

Indexed keywords

COLLAGEN; METAL; MITOMYCIN C; POLYMACON;

BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FIBROSIS; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR PRESSURE; MATERIAL STATE; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; POLYMERIZATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; REVIEW; SUBCONJUNTIVAL FIBROSIS; SUPRACHOROIDAL HEMORRHAGE; SURGICAL TECHNIQUE; TRABECULAR MESHWORK; TRABECULECTOMY;

EID: 74049103321     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.09.38     Document Type: Review

References (60)

1. Atreides S, Skuta G, Reynolds A. Wound healing modulation in glaucoma filtering surgery. Int. Ophthalmol. Clin. 44 (2), 61-106 (2004).
2. Jurk K, Kehrel B. Platelets: physiology and biochemistry. Semin. Thromb. Hemost. 31 (4), 381-392 (2005).
3. Yamanaka O, Saika S, Ikeda K, Miyazaki K, Ohnishi Y, Ooshima A. Interleukin-7 modulates extracellular matrix production and TGFβ signaling in cultured human subconjunctival fibroblasts. Curr. Eye Res. 31 (6), 491-499 (2006).
4. Saika S. TGFβ pathobiology in the eye. Lab. Invest. 86 (2), 106-115 (2006).
5. Zarbock A, Polanowska-Grabowska R, Ley K. Platelet-neutrophil interactions: linking hemostasis and inflammation. Blood Rev. 21 (2), 99-111 (2007).
6. Wong TT, Seth C, Daniels JT, Limg GA, Murph G, Khaw PT. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv. Ophthalmol. 47 (3), 239-256 (2002).
7. Hong CH, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: a systematic literature review and current controversies. Surv. Ophthalmol. 50, 48-60 (2005).
8. Ayyala RS, Harman LE, Stevens SX, Margo CE, Michelini-Norris MB, Ondrovic LE. Comparison of different biomaterials for the glaucoma drainage devices. Arch. Ophthalmol. 117, 233-236 (1999).
9. Ayyala RS, Margo CE, Michelini-Norris MB. Comparison of different biomaterials for the glaucoma drainage devices. Part 2. Arch. Ophthalmol. 118, 1081-1084 (2000).
10. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am. J. Ophthalmol. 121 (4), 349-366 (1996).
11. Singh K. Antimetabolite application: science or voodoo? J. Glaucoma 6 (5), 271-273 (1997).
12. Manche E, Afshari M, Singh K. Delayed corneal epitheliopathy after antimetaboliteaugmented trabeculectomy. J. Glaucoma 7 (4), 237-239 (1998).
13. Jacob J, Lacour O, Burgoyne C. Slow release of the antimetabolite 5-fluorouracil (5-FU) from modified Baerveldt glaucoma drains to prolong drain function. Biomaterials 22 (24), 3329-3335 (2001).
14. Mermoud A. Ex-PRESS implant. Br. J. Ophthalmol. 89 (4), 396-397 (2005).
15. The Krupin Eye Valve Filtering Surgery Study Group. Krupin eye valve with disk for filtration surgery. Ophthalmology 101 (4), 651-658 (1994).
16. Coleman AL, Hill R, Wilson MR et al. Initial clinical experience with the Ahmed Glaucoma Valve implant. Am. J. Ophthalmol. 120 (1), 23-31 (1995).
17. Ayyala RS, Zurakowski D, Smith JA et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology 105 (10), 1968-1976 (1998).
18. Huang MC, Netland PA, Coleman AL et al. Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant. Am. J. Ophthalmol. 127 (1), 27-33 (1999).
19. Topouzis F, Coleman AL, Choplin N et al. Follow-up of the original cohort with the Ahmed glaucoma valve implant. Am. J. Ophthalmol. 128 (2), 198-204 (1999).
20. Molteno AC. The optimal design of drainage implants for glaucoma. Trans. Ophthalmol. Soc. NZ 33, 39-41 (1981).
21. Minckler DS, Shammas A, Wilcox M, Ogden TE. Experimental studies of aqueous filtration using the Molteno implant. Trans. Am. Ophthalmol. Soc. 85, 368-392 (1987).
22. Heuer DK, Lloyd MA, Abrams DA et al. Which is better? One or two? A randomized clinical trial of single-plate versus doubleplate Molteno implantation for glaucomas in aphakia and pseudophakia. Ophthalmology 99 (10), 1512-1519 (1992).
23. 2 Baerveldt implant: longer term results: is bigger better? Ophthalmology 106 (12), 2312-2318 (1999).
24. Smith MF, Sherwood MB, McGorray SP. Comparison of the double-plate Molteno drainage implant with the Schocket procedure. Arch. Ophthalmol. 110 (9), 1246-1250 (1992).
25. 2 glaucoma implant and associated extraocular muscle imbalance. Ophthalmology 100 (6), 914-918 (1993).
26. 2 Baerveldt implant. Ophthalmology 101 (8), 1456-1463 (1994).
27. Siegner SW, Netland PA, Urban RC Jr et al. Clinical experience with the Baerveldt glaucoma drainage implant. Ophthalmology 102 (9), 1298-1307 (1995).
28. Ayyala RS, Durate JL, Sahiner N. Glaucoma drainage devices: state of the art. Expert Rev. Med. Devices 3 (4), 509-521 (2006).
29. Dahan E, Carmichael TR. Implantation of a miniature glaucoma device under a scleral flap. J. Glaucoma 14 (2), 98-102 (2005).
30. Filippopoulos T, Rhee DJ. Novel surgical procedures in glaucoma: advances in penetrating glaucoma surgery. Curr. Opin. Ophthalmol. 19 (2), 149-154 (2008).
31. Dahan E. Subconjunctival insertion of Ex-PRESS R-50 miniature glaucoma implant. J. Cataract Refract. Surg. 34 (5), 716-717 (2008).
32. Sarkisian SR Jr. Use of an injector for the Ex-PRESS mini glaucoma shunt. Ophthalmic Surg. Lasers Imaging 38 (5), 434-436 (2007). 504
33. Coupin A, Li Q, Riss I. Ex-PRESS miniature glaucoma implant inserted under a scleral flap in open-angle glaucoma surgery: a retrospective study. J. Fr. Ophtalmol. 30 (1), 18-23 (2007).
34. Maris PJ Jr, Ishida K, Netland PA. Comparison of trabeculectomy with Ex-PRESS miniature glaucoma device implanted under scleral flap. J. Glaucoma 16 (1), 14-19 (2007).
35. Traverso CE, De Feo F, Messas-Kaplan A et al. Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification. Br. J. Ophthalmol. 89 (4), 425-429 (2005).
36. Verbraak FD, de Bruin DM, Sulak M et al. Optical coherence tomography of the Ex-PRESS miniature glaucoma implant. Lasers Med. Sci. 20 (1), 41-44 (2005).
37. Nyska A, Glovinsky Y, Belkin M, Epstein Y. Biocompatibility of the Ex-PRESS miniature glaucoma drainage implant. J. Glaucoma 12 (3), 275-280 (2003).
38. Gandolfi S, Traverso CF, Bron A et al. Short-term results of a miniature draining implant for glaucoma in combined surgery with phacoemulsification. Acta Ophthalmol. Scand. 236 (Suppl.), 66 (2002).
39. Wamsley S, Moster MR, Rai S, Alvim HS, Fontanarosa J. Results of the use of the Ex-PRESS miniature glaucoma implant in technically challenging, advanced glaucoma cases: a clinical pilot study. Am. J. Ophthalmol. 138 (6), 1049-1051 (2004).
40. Stewart RM, Diamond JG, Ashmore ED, Ayyala RS. Complications following ex-press glaucoma shunt implantation. Am. J. Ophthalmol. 140 (2), 340-341 (2005).
41. Chen HS, Ritch R, Krupin T, Hsu WC. Control of filtering bleb structure through tissue bioengineering: an animal model. Invest. Ophthalmol. Vis. Sci. 47 (12), 5310-5314 (2006).
42. Chen HSL, Hsu WC. Initial clinical experience with biodegradable 3D porous collagen-glycosaminoglycan scaffold (iGen) for treatment of refractory glaucoma. Presented at: World Ophthalmology Congress. Sao Paulo, Brazil, 19-24 February 2006.
43. Imtiaz AS. Study of the safety and effectiveness of iGen collagen matrix implant and mitomycin C in standard glaucoma filtration surgery. Presented at: World Ophthalmology Congress. Hong Kong, 28 June-2 July 2008.
44. Aptel F, Dumas S, Denis P. Ultrasound biomicroscopy and optical coherence tomography imaging of filtering blebs after deep sclerectomy with new collagen implant. Eur. J. Ophthalmol. 19, 223-230 (2009).
45. Yuan F. Biodegradable 3D-Porous Collagen-glycosaminoglycan Scaffold for the Treatment of Refractory Glaucoma. Presented at: World Ophthalmology Congress. Hong Kong, 28 June-2 July 2008.
46. Zelefsky JR, Hsu WC, Ritch R. Biodegradable collagen matrix implant for trabeculectomy. Expert Rev. Ophthalmol. 3 (6), 613-617 (2008).
47. Kazakova D, Roters S, Schnyder CC et al. Ultrasound biomicroscopy images: long-term results after deep sclerectomy with collagen implant. Graefes Arch. Clin. Exp. Ophthalmol. 240 (11), 918-923 (2002).
48. Ates H, Uretmen O, Andac K, Azarsiz SS. Deep sclerectomy with a nonabsorbable implant (T-Flux) : preliminary results. Can. J. Ophthalmol. 38 (6), 482-488 (2003).
49. Mermoud A, Schnyder CC. Nonpenetrating filtering surgery in glaucoma. Curr. Opin. Ophthalmol. 11 (2), 151-157 (2000).
50. Dahan E, Ravinet E, Ben-Simon GJ, Mermoud A. Comparison of the efficacy and longevity of nonpenetrating glaucoma surgery with and without a new, nonabsorbable hydrophilic implant. Ophthalmic Surg. Lasers Imaging 34 (6), 457-463 (2003).
51. Dietlein TS, Jordan JF, Schild A et al. Combined cataract-glaucoma surgery using the intracanalicular eyepass glaucoma implant: first clinical results of a prospective pilot study. J. Cataract Refract. Surg. 34 (2), 247-252 (2008).
52. Spiegel D, Garcia-Feijoo J, Garcia-Sanchez J, Lamielle H. Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv. Ther. 25 (5), 453-464 (2008).
53. Spiegel D, García-Feijoó J, García-Sánchez J, Lamielle H. Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv. Ther. 25 (5), 453-464 (2008).
54. Noecker RS, Dirks MS, Choplin NT et al. A six-month randomized clinical trial comparing the intraocular pressurelowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma Presented at: The American Glaucoma Society Annual Meeting. Athens, Greece, 28-31 March 2007.
55. Simon G, Melamed S, Goldenfeld M, Clevenger J. Gold microshunt for the reduction of IOP. Presented at: The International Glaucoma Society Meeting. Athens, Greece, 28-31 March, 2007.
56. Hinkle DM, Zurakowski D, Ayyala RS. Comparison of the polypropylene plate Ahmed™ valve to the silicone plate Ahmed™. Eur. J. Ophthalmol. 17 (5), 696-701 (2007).
57. Ishida K, Netland PA, Costa VP, Siroma L, Khan B, Ahmed IK. Comparison of polypropylene and silicone Ahmed glaucoma valve. Ophthalmology 113, 1320-1326 (2006).
58. Blake DA, Clinton AD, Galler KE, Johnson PY, Sahiner N, Ross ND, John VT, Walsh M, Ayyala RS. Inhibition of cell proliferation by mitomycin C incorporated into p (HEMA) hydrogels. J. Glaucoma 15, 291-298 (2006).
59. Pan T, Brown JD, Ziaie B. An artificial nano-drainage implant (ANDI) for glaucoma treatment. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1, 3174-3177 (2006).
60. Sahiner N, Kravitz DJ, Qadir R et al. Creation of a drug-coated glaucoma drainage device using polymer technology: in vitro and in vivo studies. Arch. Ophthalmol. 127 (4), 448-453 (2009).